Si Wu
Shijiazhuang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Deep learning-based assessment of HER2-ultralow expression in breast cancer: a multi-center validation study across primary and metastatic lesions.
Journal: Virchows Archiv : an international journal of pathology
Published: April 15, 2026
Multimodal artificial intelligence predicts PIK3CA mutation in breast cancer from digital pathology and clinical data: a multicenter study.
Journal: Cancer biology & medicine
Published: April 13, 2026
HER2-low as a unique subgroup in breast cancer: insights from neoadjuvant chemotherapy response and survival analysis.
Journal: Journal of clinical pathology
Published: March 08, 2026
HER2 testing in multifocal/multicentric breast cancer: should all foci be tested in the context of HER2-low and HER2-ultralow?
Journal: Breast (Edinburgh, Scotland)
Published: May 14, 2025
Establishment of multiple machine learning prognostic model for gene differences between primary tumors and lymph nodes in luminal breast cancer.
Journal: Breast cancer research and treatment
Published: August 30, 2024
Artificial intelligence for assisted HER2 immunohistochemistry evaluation of breast cancer: A systematic review and meta-analysis.
Journal: Pathology, research and practice
Published: April 22, 2024
Prognostic factors of patients with human epidermal growth factor receptor 2-positive breast cancer following neoadjuvant therapy: Development and validation of a predictive nomogram.
Journal: Pathology, research and practice
Published: September 09, 2023
Effect of storage time of paraffin sections on the expression of PD-L1 (SP142) in invasive breast cancer.
Journal: Diagnostic pathology
Published: July 19, 2023
Clinicopathological features and prognostic analysis of HER2 low and fibrotic focus in HER2-negative breast cancer.
Journal: Breast cancer research and treatment
Published: June 07, 2023
Construction and validation of a nomogram for predicting the prognosis of patients with lymph node-positive invasive micropapillary carcinoma of the breast: based on SEER database and external validation cohort.
Journal: Frontiers in oncology
Published: May 30, 2023
RT-qPCR is helpful to distinguish the clinicopathological features of HER2 immunohistochemistry 0 and 1.
Journal: Pathology, research and practice
Published: January 29, 2023
Evolution and clinical significance of HER2-low status after neoadjuvant therapy for breast cancer.
Journal: Frontiers in oncology
Published: November 01, 2022
Last Updated: 09/26/2026